pillbase.ru

Bosulif

Active substance: bosutinib

bosutinib (as monohydrate)

Centralised EU authorisationActive

Marketing holder: Pfizer Europe MA EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
  • bosutinib (as monohydrate)
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 11
  • BOSULIF
    CAPSULE · BOSUTINIB MONOHYDRATE 50 mg/1
    0069-0504
    Pfizer Laboratories Div Pfizer Inc
  • BOSULIF
    TABLET, FILM COATED · BOSUTINIB MONOHYDRATE 400 mg/1
    63539-193
    U.S. Pharmaceuticals
  • BOSULIF
    TABLET, FILM COATED · BOSUTINIB MONOHYDRATE 400 mg/1
    0069-0193
    Pfizer Laboratories Div Pfizer Inc
  • BOSULIF
    CAPSULE · BOSUTINIB MONOHYDRATE 100 mg/1
    0069-1014
    Pfizer Laboratories Div Pfizer Inc
  • BOSULIF
    TABLET, FILM COATED · BOSUTINIB MONOHYDRATE 500 mg/1
    0069-0136
    Pfizer Laboratories Div Pfizer Inc
All products in this country (11)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3ddf-765e-92c1-65eba9d8a1a8,01a1208c-8a1a-7571-8caa-ceb7bfde7374,01a1208c-900f-7e49-99b0-1b5fffd8825b,01a1208f-b7e4-72da-b11a-f5ceda45b1ac,01a1208f-b7e6-7f72-9b38-7423a2d8ca1d;count=11 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002373
Registration status
Active
ATC code
L01EA04
Sources
  • product · EMA · EMEA/H/C/002373 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002373 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002373 · Verified 2026-10-09